New Mexico Healthcare
Compliance Guide

New Mexico presents a generally favorable regulatory environment for healthcare companies, including those leveraging telehealth, though it maintains robust consumer protection and professional oversight. The state has historically been progressive in its adoption of telehealth, particularly accelerated by the COVID-19 pandemic, and has codified many of these flexibilities into permanent law. Key regulatory bodies include the New Mexico Medical Board (NMMB), the New Mexico Board of Pharmacy (NMBOP), and various professional licensing boards. The state's general business climate is conducive to healthcare innovation, but companies must navigate specific regulations concerning the Corporate Practice of Medicine (CPOM), professional licensing, and prescribing practices. Recent legislative actions have focused on solidifying telehealth parity, expanding access to care, and refining controlled substance regulations. For instance, the passage of legislation ensuring payment parity for telehealth services has significantly de-risked financial models for telehealth providers. While CPOM is enforced, New Mexico offers structured pathways for non-physician ownership and management through compliant MSO arrangements. The state's embrace of advanced practice providers, including full practice authority for Nurse Practitioners, further enhances its appeal for diverse healthcare delivery models. Companies looking to expand into New Mexico must prioritize meticulous adherence to licensing requirements, understanding the nuances of CPOM, and ensuring their telehealth and prescribing protocols align with state statutes and board rules. The state's commitment to expanding healthcare access, particularly in rural and underserved areas, often translates into supportive policies for innovative care delivery, provided it meets quality and safety standards. However, the NMMB and NMBOP remain vigilant in enforcing professional standards, particularly regarding the appropriate establishment of a patient-provider relationship and the responsible prescribing of controlled substances.

New Mexico enforces the Corporate Practice of Medicine (CPOM) doctrine, albeit with some flexibility compared to stricter states. The legal basis for CPOM in New Mexico is primarily derived from statute and regulatory interpretation by the New Mexico Medical Board (NMMB) and other professional licensing boards, rather than explicit case law establishing a broad common law prohibition. The core principle is that medical decisions and the practice of medicine must remain under the control of licensed professionals. New Mexico Statutes Annotated (NMSA) § 61-6-15, which prohibits the unlicensed practice of medicine, implicitly supports the CPOM doctrine by preventing corporations or lay entities from employing physicians in a manner that interferes with their independent professional judgment or allows the corporation to profit directly from the medical services themselves. Consequently, non-physicians generally cannot directly own entities that employ physicians to provide medical services. This restriction extends to various healthcare businesses, including medspas, dental practices, and wellness clinics, where the professional services must be rendered by or under the direct control of a licensed professional. For example, a medspa offering medical aesthetic services (e.g., injectables, laser treatments) must ensure the medical services component is owned and operated by a licensed physician or a professional entity, even if the non-medical spa services are owned by a lay entity. However, New Mexico permits the use of management services organizations (MSOs) as a compliant structure. An MSO, owned by non-physicians, can provide administrative, non-clinical services (e.g., billing, marketing, IT, real estate) to a physician-owned professional entity (PC). The PC, in turn, employs the licensed healthcare professionals and delivers the clinical services. The MSO charges the PC a fair market value fee for its services, ensuring that the MSO does not engage in fee-splitting or exert control over clinical decision-making. This structure allows for non-physician investment and management expertise while preserving the professional integrity of the medical practice. Telehealth companies operating in New Mexico must also adhere to CPOM. If a telehealth company directly employs physicians to provide medical services, it must be structured as a professional entity owned by licensed physicians. Alternatively, a telehealth platform can partner with physician-owned professional corporations through MSO arrangements. The key is to ensure that the entity providing the medical services is professionally owned and controlled, and that any non-clinical management entity does not interfere with the physician's independent medical judgment. Violations of CPOM can lead to severe penalties, including license revocation for professionals and injunctions against the business entity. Therefore, careful structuring is paramount.

New Mexico has established a robust framework for telehealth, largely codified in NMSA § 24-1I-1 et seq., the 'Telehealth Act.' This act, along with regulations from the New Mexico Medical Board (NMMB) and other licensing boards, clarifies the permissibility and requirements for telehealth services. Establishment of Patient-Provider Relationship: New Mexico explicitly allows for the establishment of a patient-provider relationship via telehealth, provided that the standard of care is met. This means an in-person physical examination is not necessarily required to initiate care, as long as the provider can gather sufficient information through telehealth modalities to make a diagnosis and formulate a treatment plan consistent with generally accepted medical practice. The NMMB's rules, such as 16.10.19 NMAC, emphasize that the telehealth encounter must be equivalent to an in-person visit in terms of quality and appropriateness. Permitted Modalities: New Mexico is highly flexible regarding telehealth modalities. It permits synchronous audio-visual (video conferencing), synchronous audio-only (telephone), and asynchronous (store-and-forward) technologies. The choice of modality should be clinically appropriate for the service being rendered. While video is generally preferred for initial consultations and complex diagnoses, audio-only is permissible when clinically appropriate and when video is not available or suitable. Asynchronous modalities are acceptable for certain services, such as reviewing images or patient-submitted data, but typically not for establishing an initial diagnosis requiring interactive communication. Telehealth Registration Requirements: There are no specific standalone 'telehealth registration' requirements for providers beyond their standard professional licensing. A provider licensed in New Mexico can provide telehealth services within their scope of practice. However, out-of-state providers must be licensed in New Mexico to provide services to patients located in New Mexico, unless they qualify under specific interstate compacts (e.g., IMLC, NLC) or temporary licensure provisions. Informed Consent Requirements: Informed consent for telehealth is mandatory. Providers must obtain informed consent from the patient (or their legal representative) prior to initiating telehealth services. This consent should include, but is not limited to, information about the nature of telehealth, potential risks and benefits, privacy and security measures, and the patient's right to withdraw consent. NMSA § 24-1I-4 requires that patients be informed of their rights and responsibilities, including confidentiality. Geographic Restrictions: There are generally no geographic restrictions within New Mexico for telehealth services, meaning a provider licensed in New Mexico can provide telehealth to any patient located anywhere within the state. However, providers must be mindful of their own physical location during the telehealth encounter, ensuring they are licensed in the jurisdiction where they are physically located if that jurisdiction has specific requirements for providing telehealth across state lines. For patients located outside New Mexico, the provider must be licensed in that patient's state of residence.

New Mexico maintains stringent regulations for prescribing controlled substances, particularly via telehealth, which are primarily governed by the New Mexico Board of Pharmacy (NMBOP) and the New Mexico Medical Board (NMMB), in conjunction with federal DEA rules. Schedules Prescribable via Telehealth: All schedules of controlled substances (Schedules II-V) can potentially be prescribed via telehealth in New Mexico, provided that the prescribing physician has established a legitimate patient-provider relationship, conducted an appropriate medical evaluation, and determined that the prescription is for a legitimate medical purpose in the usual course of professional practice. However, the NMMB and NMBOP emphasize that the standard of care for prescribing controlled substances via telehealth is the same as for in-person care, often requiring a thorough initial assessment. DEA Requirements: Federal DEA regulations, particularly the Ryan Haight Online Pharmacy Consumer Protection Act, mandate an in-person medical evaluation or an evaluation by a referring practitioner prior to prescribing controlled substances via the internet, with specific exceptions. During the COVID-19 Public Health Emergency (PHE), these in-person requirements were waived. As of the anticipated 2025-2026 timeframe, the DEA has proposed new rules that would largely reinstate the in-person requirement for Schedule II and certain Schedule III-V controlled substances, with some exceptions for a 30-day supply following an initial telehealth evaluation. Providers must monitor the finalization of these DEA rules closely. PDMP Checking Required: Yes, New Mexico mandates the checking of the Prescription Drug Monitoring Program (PDMP) database. NMSA § 26-2-12.1 requires prescribers to review the patient's prescription history in the New Mexico PDMP prior to prescribing an opioid or benzodiazepine, and periodically thereafter for ongoing treatment. This applies to both in-person and telehealth encounters. Quantity or Refill Limitations: New Mexico has specific quantity and refill limitations, particularly for opioids. For acute pain, initial opioid prescriptions are generally limited to a 5-day supply, with exceptions for trauma, surgery, or chronic conditions documented in the medical record. Subsequent prescriptions require re-evaluation. Refills for Schedule II substances are generally prohibited, and Schedule III-V substances are limited to five refills within six months. Special Rules for Specific Drug Classes: GLP-1s (e.g., Ozempic, Wegovy): While not controlled substances, prescribing GLP-1s for weight loss or diabetes management via telehealth requires a comprehensive medical evaluation, including patient history, physical assessment (which may require in-person components or remote monitoring), and appropriate lab work. Off-label prescribing for weight loss must be clinically justified and documented. Testosterone: As a Schedule III controlled substance, testosterone prescribing via telehealth must adhere to the Ryan Haight Act's requirements (post-PHE), meaning an initial in-person exam or qualified referral, unless specific DEA exceptions apply. Ongoing monitoring and lab work are critical. Stimulants (e.g., Adderall, Ritalin): As Schedule II controlled substances, stimulants for ADHD or narcolepsy are subject to the strictest prescribing rules. Post-PHE, an initial in-person evaluation is likely required by federal DEA rules for new prescriptions. Ongoing management via telehealth may be permissible if a robust patient-provider relationship is established and maintained, with regular monitoring and PDMP checks. Providers must exercise extreme caution and document thoroughly to demonstrate medical necessity and adherence to the standard of care for all controlled substance prescribing via telehealth.

New Mexico has a progressive approach to the scope of practice for advanced practice providers, particularly Nurse Practitioners (NPs), which significantly impacts healthcare delivery models. Full Practice Authority for NPs: Yes, New Mexico grants full practice authority to Nurse Practitioners. This means NPs in New Mexico can practice independently, diagnose, treat, and prescribe medications (including controlled substances) without the direct supervision or collaborative practice agreement of a physician, provided they meet specific educational and certification requirements. The Nurse Practice Act (NMSA § 61-3-23.3) and rules promulgated by the Board of Nursing (16.12.2 NMAC) delineate this authority. NPs must obtain an 'advanced practice' license and meet specific clinical hour requirements. This full practice authority makes New Mexico an attractive state for telehealth companies seeking to leverage NP talent. PAs and Collaborative Practice: Physician Assistants (PAs) in New Mexico operate under a collaborative practice model. While PAs have a broad scope of practice, including diagnosing, treating, and prescribing, their practice must occur within the context of a collaborative practice agreement with a supervising physician. NMSA § 61-6-11 and rules from the Medical Board (16.10.10 NMAC) govern PA practice. The collaborative agreement outlines the PA's scope of practice, which is delegated by the supervising physician, and includes provisions for consultation, referral, and review of patient charts. The level of supervision required is determined by the physician and PA, considering the PA's experience and the complexity of the practice, but the physician retains ultimate responsibility. Other Mid-Level Providers: New Mexico also recognizes other advanced practice providers, such as Certified Nurse Midwives (CNMs) and Clinical Nurse Specialists (CNSs), who also have broad practice authority within their specialized fields. Delegation Rules for Medical Assistants in Medspas: Medical Assistants (MAs) in New Mexico generally operate under the direct supervision of a licensed physician, NP, or PA. Their scope of practice is limited to administrative and certain clinical tasks that do not require independent medical judgment. In medspas, MAs can perform tasks like taking vital signs, preparing patients, and assisting with procedures, but they cannot independently perform medical aesthetic procedures such as injections (e.g., Botox, fillers), laser treatments, or chemical peels. These procedures constitute the practice of medicine and must be performed by or under the direct, on-site supervision of a licensed physician, NP, or PA. Delegation of such procedures to MAs is strictly prohibited and would constitute the unlicensed practice of medicine. Supervision Requirements: For professions requiring supervision or collaboration (e.g., PAs, MAs), the supervising licensed professional is ultimately responsible for the care provided. The degree of supervision varies by profession and task, from direct, on-site supervision for certain procedures to less direct oversight for routine tasks. Telehealth companies must ensure that their operational models for all providers align with these specific scope of practice and supervision requirements to avoid regulatory violations.

Navigating business structures in New Mexico requires careful attention to the Corporate Practice of Medicine (CPOM) doctrine and professional licensing laws. PC-MSO Structures: The Professional Corporation (PC) and Management Services Organization (MSO) structure is the predominant compliant model for healthcare businesses in New Mexico where non-physician ownership or investment is involved. A PC, owned exclusively by licensed physicians (or other licensed professionals like NPs for their respective services), employs the clinical staff and provides the medical services. The MSO, which can be owned by non-physicians, provides all non-clinical, administrative, and management services to the PC. This includes services like billing, marketing, IT, real estate, human resources for administrative staff, and equipment leasing. The MSO charges the PC a fair market value (FMV) fee for these services. This separation ensures that clinical decisions remain solely with the licensed professionals in the PC, while allowing for external investment and management expertise. Fee-Splitting Rules: New Mexico has strict prohibitions against fee-splitting, which is the practice of sharing professional fees with unlicensed individuals or entities for patient referrals or services. NMSA § 61-6-15 and NMMB rules (e.g., 16.10.19.8 NMAC) prohibit physicians from splitting fees with, or paying commissions to, any person for referring patients. The MSO fee must be structured as a fixed fee or a percentage of gross revenues that is consistent with FMV for the services rendered, and critically, it must not be tied to the volume or value of referrals or directly to the professional fees generated by the PC. Any arrangement that appears to incentivize referrals or share in professional fees could be construed as illegal fee-splitting. Management Services Agreement Requirements: A comprehensive Management Services Agreement (MSA) is crucial for a PC-MSO structure. The MSA must clearly delineate the services provided by the MSO, the fee structure (FMV-based), the MSO's lack of control over clinical decisions, and the PC's sole authority over medical practice. It should also address compliance with HIPAA, state privacy laws, and other relevant regulations. The terms must be commercially reasonable and defensible as FMV. Professional Corporation Requirements: To form a Professional Corporation (PC) in New Mexico, the entity must be organized under the Professional Corporation Act (NMSA § 53-6-1 et seq.). The shareholders, directors, and officers of a medical PC must generally be licensed physicians. Similarly, for other professional services (e.g., nursing, dentistry), the respective licensees must own the professional entity. The name of the PC must comply with state rules, often including 'P.C.' or 'PA'. How to Structure Ownership for Compliance: For telehealth companies, medspas, dental practices, and wellness clinics, the ownership structure must segregate clinical and non-clinical functions. The entity directly employing or contracting with licensed professionals to provide medical services must be a professional entity owned by licensed professionals. The administrative and technological platform, which may be owned by non-professionals, should function as an MSO, providing services to the professional entity under an MSA. This dual entity structure is the most common and legally defensible approach to comply with New Mexico's CPOM and anti-fee-splitting laws while allowing for broader investment and operational flexibility. Failure to correctly implement this structure can lead to severe regulatory penalties, including cease and desist orders, fines, and professional license actions.

New Mexico has continued to evolve its healthcare regulatory landscape, with several key developments and ongoing legislative considerations impacting telehealth, CPOM, and prescribing practices. Telehealth Parity Permanence: A significant development in recent years was the permanent codification of telehealth payment parity. While the exact bill number can vary by legislative session, the intent has been to ensure that services delivered via telehealth are reimbursed at the same rate as in-person services, provided they meet the same standard of care. This has provided stability for telehealth providers and is expected to continue through 2025-2026. Interstate Licensure Compacts: New Mexico is an active participant in several interstate licensure compacts, which streamline the licensing process for out-of-state providers. It is a member of the Interstate Medical Licensure Compact (IMLC), allowing physicians to obtain expedited licensure. It is also a member of the Nurse Licensure Compact (NLC), enabling registered nurses and licensed practical nurses to practice in other compact states. For other professions, such as physical therapy and psychology, New Mexico is also exploring or has joined relevant compacts. Companies should monitor the status of these compacts for their specific provider types. Controlled Substance Prescribing Updates: The New Mexico Board of Pharmacy and Medical Board regularly update rules regarding controlled substance prescribing, often in response to federal DEA actions. As of late 2024 and into 2025-2026, the primary focus will be on the finalization and implementation of the DEA's proposed rules for telehealth prescribing of controlled substances, which aim to reinstate some form of the in-person examination requirement post-PHE. New Mexico's state boards will likely issue guidance or adopt parallel rules to align with federal mandates while maintaining state-specific PDMP requirements and limitations. GLP-1 and Weight Loss Clinic Scrutiny: There has been increased regulatory scrutiny nationally, and likely within New Mexico, regarding the proliferation of weight loss clinics, particularly those prescribing GLP-1 agonists. Boards are emphasizing the need for comprehensive medical evaluations, appropriate patient selection, and ongoing monitoring, even in telehealth settings. Expect potential board guidance or enforcement actions targeting practices that fall short of the standard of care in this area. CPOM Enforcement: While no major legislative changes to CPOM are anticipated, the NMMB and other professional boards continue to actively enforce existing prohibitions through investigations and disciplinary actions. Companies should remain vigilant in ensuring their MSO structures are robust and compliant, as enforcement often arises from complaints regarding unlicensed practice or fee-splitting. Behavioral Health Expansion: New Mexico continues to prioritize access to behavioral health services, including through telehealth. Expect continued support for telehealth modalities in mental health and substance use disorder treatment, potentially with further reimbursement enhancements or grant opportunities.

For healthcare companies entering or expanding in New Mexico, a proactive and meticulous approach to compliance is essential. Step-by-Step Compliance Checklist: 1. Entity Formation: Establish a compliant professional entity (PC) for clinical services, owned by licensed New Mexico professionals, and a separate MSO for administrative services, owned by investors. 2. Licensure: Ensure all healthcare professionals are fully licensed in New Mexico, or eligible under interstate compacts. Initiate licensing applications well in advance, as processing times can vary. 3. MSO Agreement: Draft a robust Management Services Agreement (MSA) between the PC and MSO, ensuring fair market value for services and strict separation of clinical control. 4. Telehealth Protocols: Develop comprehensive telehealth policies and procedures covering patient-provider relationship establishment, informed consent, modality use, data security (HIPAA), and emergency protocols, all aligned with NMSA § 24-1I-1 et seq. and board rules. 5. Prescribing Policies: Implement strict controlled substance prescribing policies, including mandatory PDMP checks, adherence to state quantity limits, and compliance with federal DEA rules (especially post-PHE for telehealth). 6. Scope of Practice: Verify that all providers (NPs, PAs, MAs) operate strictly within their New Mexico-defined scope of practice and supervision requirements. 7. Billing & Reimbursement: Understand New Mexico's payment parity laws and payer-specific requirements for telehealth billing. Common Pitfalls to Avoid: * Underestimating CPOM: Assuming a lax CPOM environment can lead to illegal ownership structures and severe penalties. * Inadequate Patient-Provider Relationship: Failing to conduct a thorough initial evaluation via telehealth that meets the standard of care, especially for controlled substances. * Fee-Splitting: Structuring MSO fees based on a percentage of professional fees or patient referrals, rather than fair market value for administrative services. * Ignoring PDMP: Not checking the New Mexico PDMP for controlled substance prescriptions. * Out-of-State Licensure Issues: Providing telehealth services to New Mexico patients without proper New Mexico licensure or compact privileges. * Delegating Beyond Scope: Allowing unlicensed personnel (e.g., MAs) to perform procedures requiring a licensed professional. Timeline Expectations for Licensing and Setup: * Professional Licensing: Expect 3-6 months for initial physician and NP licensure, potentially longer if there are prior disciplinary actions or complex background checks. Interstate compacts can expedite this. * Entity Formation: 2-4 weeks for state registration of PC and MSO. * MSA Drafting & Review: 1-2 months, depending on complexity and legal review. * Policy & Procedure Development: 1-2 months for comprehensive, state-specific protocols. Total setup can range from 4-9 months, emphasizing the need for early planning and engagement with legal counsel specializing in New Mexico healthcare law.